{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T19:10:03Z","timestamp":1727032203115},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,22]]},"DOI":"10.7759\/cureus.69929","type":"journal-article","created":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T18:30:16Z","timestamp":1727029816000},"source":"Crossref","is-referenced-by-count":0,"title":["Spectrum of Ductal Carcinoma In Situ (DCIS) Lesions of the Breast: From Morphology to Molecular Characteristics"],"prefix":"10.7759","author":[{"given":"Guttikonda","family":"Sathvik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavithra","family":"V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena D","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chithra Bhanu","family":"Challa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606021","article-title":"Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease","volume":"104","author":"Clark SE","year":"2011","unstructured":"Clark SE, Warwick J, Carpenter R, Bowen RL, Duffy SW, Jones JL. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer. 2011, 104:120-7. 10.1038\/sj.bjc.6606021","journal-title":"Br J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou CM","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, et al.. Molecular portraits of human breast tumours. Nature. 2000, 406:747-52. 10.1038\/35021093","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie T","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, et al.. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001, 98:10869-74. 10.1073\/pnas.191367098","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/s0046-8177(03)00411-8","article-title":"Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer","volume":"34","author":"Makretsov N","year":"2003","unstructured":"Makretsov N, Gilks CB, Coldman AJ, et al.. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol. 2003, 34:1001-8. 10.1053\/s0046-8177(03)00411-8","journal-title":"Hum Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen TO","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, et al.. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004, 10:5367-74. 10.1158\/1078-0432.CCR-04-0220","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4137\/bmi.s2185","article-title":"Immunohistochemistry as an important tool in biomarkers detection and clinical practice","volume":"5","author":"Matos LL","year":"2010","unstructured":"Matos LL, Trufelli DC, de Matos MG, da Silva Pinhal MA. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights. 2010, 5:9-20. 10.4137\/bmi.s2185","journal-title":"Biomark Insights"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang MC","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, et al.. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009, 101:736-50. 10.1093\/jnci\/djp082","journal-title":"J Natl Cancer Inst"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey JM","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. Journal of Clinical Oncology. 1999, 17:1474-81.","journal-title":"Journal of Clinical Oncology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00206","article-title":"HER2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update summary","volume":"14","author":"Wolff AC","year":"2018","unstructured":"Wolff AC, Hammond ME, Allison KH, Harvey BE, McShane LM, Dowsett M. HER2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update summary. J Oncol Pract. 2018, 14:437-41. 10.1200\/JOP.18.00206","journal-title":"J Oncol Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group","volume":"103","author":"Dowsett M","year":"2011","unstructured":"Dowsett M, Nielsen TO, A'Hern R, et al.. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst. 2011, 103:1656-64. 10.1093\/jnci\/djr393","journal-title":"J Natl Cancer Inst"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv062","article-title":"Molecular phenotypes of DCIS predict overall and invasive recurrence","volume":"26","author":"Williams KE","year":"2015","unstructured":"Williams KE, Barnes NL, Cramer A, et al.. Molecular phenotypes of DCIS predict overall and invasive recurrence. Ann Oncol. 2015, 26:1019-25. 10.1093\/annonc\/mdv062","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2128","article-title":"Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer","volume":"10","author":"Tamimi RM","year":"2008","unstructured":"Tamimi RM, Baer HJ, Marotti J, et al.. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008, 10:R67. 10.1186\/bcr2128","journal-title":"Breast Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4878","article-title":"Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ","volume":"92","author":"Barnes NL","year":"2005","unstructured":"Barnes NL, Boland GP, Davenport A, Knox WF, Bundred NJ. Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ. Br J Surg. 2005, 92:429-34. 10.1002\/bjs.4878","journal-title":"Br J Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.03.019","article-title":"Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy","volume":"64","author":"Yang L","year":"2022","unstructured":"Yang L, Shen M, Qiu Y, Tang T, Bu H. Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy. Breast. 2022, 64:1-6. 10.1016\/j.breast.2022.03.019","journal-title":"Breast"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01876-9","article-title":"The clinical significance of HER2 expression in DCIS","volume":"40","author":"Akrida I","year":"2022","unstructured":"Akrida I, Mulita F. The clinical significance of HER2 expression in DCIS. Med Oncol. 2022, 40:16. 10.1007\/s12032-022-01876-9","journal-title":"Med Oncol"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/217060","article-title":"A comparative analysis of biomarker expression and molecular subtypes of pure ductal carcinoma in situ and invasive breast carcinoma by image analysis: relationship of the subtypes with histologic grade, Ki67, p53 overexpression, and DNA ploidy","volume":"2011","author":"Sarode VR","year":"2011","unstructured":"Sarode VR, Han JS, Morris DH, Peng Y, Rao R. A comparative analysis of biomarker expression and molecular subtypes of pure ductal carcinoma in situ and invasive breast carcinoma by image analysis: relationship of the subtypes with histologic grade, Ki67, p53 overexpression, and DNA ploidy. Int J Breast Cancer. 2011, 2011:217060.","journal-title":"Int J Breast Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2416-z","article-title":"Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile","volume":"473","author":"Takahashi S","year":"2018","unstructured":"Takahashi S, Thike AA, Koh VC, Sasano H, Tan PH. Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile. Virchows Arch. 2018, 473:275-83. 10.1007\/s00428-018-2416-z","journal-title":"Virchows Arch"},{"key":"ref18","article-title":"Histological and immunohistochemical evaluation of ductal carcinoma in situ co-existing with triple-negative carcinoma of the breast","volume":"42","author":"Seol H","year":"2008","unstructured":"Seol H, Ko H, Park I. Histological and immunohistochemical evaluation of ductal carcinoma in situ co-existing with triple-negative carcinoma of the breast. Korean Journal of Pathology. 2008, 42:373-80.","journal-title":"Korean Journal of Pathology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/297319-spectrum-of-ductal-carcinoma-in-situ-dcis-lesions-of-the-breast-from-morphology-to-molecular-characteristics","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T18:30:19Z","timestamp":1727029819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/297319-spectrum-of-ductal-carcinoma-in-situ-dcis-lesions-of-the-breast-from-morphology-to-molecular-characteristics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.69929","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,22]]}}}